While healthcare consumers, healthcare services, and healthcare financing institutions could all potentially benefit from the broader adoption of generative AI, the risks of such a shift are primarily borne by consumers.

In this submission to the Australian Department of Health and Aged Care consultation "Safe and Responsible Artificial Intelligence in Healthcare - Legislation and Regulation Review", CHF discusses the consequences that the unregulated adoption of generative AI could bring to healthcare consumers, providing recommendations on how to mitigate such risks while implementing legislative and regulatory reforms.

In the submission, CHF also presents also interim findings from Australia’s Health Panel AI survey, performed in June 2024.